Pendrea Bio, Inc.

Private

Boalsburg, PennsylvaniaN/Ahttps://grokipedia.com/

Last Round

Series A

Oct 1, 2020

Total Funding Raised

$4.5M

Company Overview

Pendrea Bio, Inc. is a biotechnology company that develops nanotechnology platforms, including calcium-phosphate NanoJackets for RNA therapeutics and photo-immuno nano therapy for oncology applications.

Keywords

nanotechnologydrug deliverynanomedicineoncology therapeuticsRNA therapeuticsprecision medicinenanoparticle platformsolid tumor treatmentgene therapyclinical-stage biotechbiotech startupdrug developmentSBIR grantsnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pendrea Bio, Inc. Comparables

Compare Pendrea Bio, Inc. with similar companies based on industry and business-model similarity.

Pendrea Bio, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Cello Therapeutics	79%
TransCode Therapeutics, Inc.	79%
Duo Oncology	79%

View all Comparables

Pendrea Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 1, 2020
Seed	Oct 1, 2020
Grant	Oct 5, 2015

View all Funding Rounds

Pendrea Bio, Inc. Investors

Notable investors and investment history

Pendrea Bio, Inc. investors
Investor	Rounds
National Cancer Institute	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 1, 2020
$20M round completed.

View all signals

Pendrea Bio, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pendrea Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pendrea Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBoalsburg, Pennsylvania

Employee Range1

Year Founded2005

Last FundingOct 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?